3-month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: results from an Italian, open, multicenter trial.

Authors
Publication date
1 January 2003
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Institutional Research Information System University of Turin

    redirect
    oaioai:iris.unito.it:2318/40090
    Last time updated on 02/03/2023